Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bristol-Myers Squibb Co BMY

Bristol-Myers Squibb Company is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor (CAR-T) cell therapies. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are used as well. Biologics are administered to patients through injections or by intravenous infusion. Its in-line products include Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Yervoy, Sprycel, Reblozyl, Opdualag, Abecma, Zeposia, and others. The Company's product pipeline includes Krazati, MRTX1719, RYZ101, KarXT, ORM-6151, and Repotrectinib.


NYSE:BMY - Post by User

Comment by zeropointenergyon Oct 08, 2021 12:32am
110 Views
Post# 33987300

RE:Great Awakening

RE:Great Awakening

May 10, 2021 · Many regions around the world now recognise that ivermectin is powerful prophylaxis and treatment for Covid-19. South Africa, Zimbabwe, Slovakia, Czech Republic,A five-day course of ivermectin for the treatment of COVID-19 ...

A 5-day course of ivermectin was found to be safe and effective in treating adult patients with mild COVID-1Ivermectin for Prevention and Treatment of COVID-19 Infection ...

Jun 21, 2021 · For example, Peru had a very high death toll from COVID-19 early on in the pandemic. 128 Based on observational evidence, the Peruvian government approved ivermectin for

The incidence in mortality rates and number of cases is significantly lowe  it works and covid 19 is over if all countries use it!


<< Previous
Bullboard Posts
Next >>